General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS UK PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-Sep-2026 12:12:35
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG260908OTHR3C22
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
08/09/2026 09:00:00
Description (Please provide a detailed description of the event in the box below)
Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil

Attachments

Biocon_SGX_Pertu_Brazil_08092026.pdf
Total size =295K